Context sidebar

Overview - FAQ

Clinical trials

Q&A and important links

Transplant products

FAQ - Definitionen

Pharmacovigilance

Pharmacovigilance

FAQ General Pharmacovigilance

FAQ ElViS

FAQ Pharmacovigilance-Inspections (GVP, Good Pharmacovigilance Practices)

Haemovigilance

Medicinal products from the Internet

Importing and exporting medicinal products by individuals - Questions & answers

Guideline on medicines and the Internet

Advertising of medicinal products

FAQ

Complementary & herbal medicines

Frequently Asked Questions on CHMs – FAQ CHM

Medical devices

Regulation of medical devices - Questions frequently asked by patients

System for issuing Export Certificates (FSC) for medical devices – Questions and answers

New EU regulations (MDR, IVDR) - Frequently Asked Questions

Guidance documents TPO4

Questions and answers on variations and extensions HMP

Questions and answers on Art. 14 para. 1 letter abis-quater TPA

Questions and answers on the Paediatric Investigation Plan

Questions and answers on document protection

Questions and answers Art. 13 TPA

Questions and answers Swiss Public Assessment Report (SwissPAR)

Questions and answers on the authorisation of biosimilars

Questions and answers on orphan drug/MUMS

Questions and answers on co-marketing

Questions and answers on authorisation renewals

Questions and answers on Full declaration HMV4

Last modification 20.03.2023

Top of page